Behind the Breakthrough

Promising new treatment for Parkinson’s Disease

November 21, 2022

Dr. Lorraine Kalia’s research looks at testing different compounds in C. Elegans and how it can lead to a better understanding of Parkinson’s disease and new therapeutic targets. The best part: some of these compounds are already approved for use in humans. Through Dr. Kalia’s research we may be able to repurpose these compounds for the neurodegenerative condition.

Podbean App

Play this podcast on Podbean App